Pharma Pathway

FEBRUARY 14, 2023

Hetero Labs Limited-Placement Drive for Freshers in Production/ QA QC/ Engineering On 16th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 84

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 84

Pharma Pathway

FEBRUARY 12, 2023

Chemistry/ B.Com Freshers On 14th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 79

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 79

Pharma Pathway

FEBRUARY 4, 2023

Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023 Job Description Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

FEBRUARY 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in Production/Packing/ QA/ Stores On 4th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

Pharma Pathway

MARCH 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in QC -Instrumentation On 4th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

JANUARY 5, 2023

Walk-In Drive for Multiple Positions On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Job Description.

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

FEBRUARY 20, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 21st Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

FEBRUARY 2, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Quality Control/ Quality Assurance/ Production On 5th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Chemist Qualification: B.Sc

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for AR&D/ FR&D/ Analytical DQA On 28th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Method Validation 79

Method Validation Biosimilars Pharmaceutical Companies Pharmaceutical Companies 79

Pharma Pathway

JANUARY 26, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QC/ QA/ R&D/ Production/ HR/ Maintenance On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 74

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 74

Pharma Pathway

FEBRUARY 16, 2023

in Regulatory Affairs On 17th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 30, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC/ Production On 3rd Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 4, 2023

On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Company Name: Dr. Reddy’s Laboratories.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

Express Pharma

OCTOBER 6, 2023

Biocon has signed a partnership agreement with Juno Pharmaceuticals, a specialty pharmaceutical company in Canada, for the commercialisation of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity.

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

APRIL 18, 2024

a specialty pharmaceutical company in Brazil, for the commercialisation of its vertically integrated drug product, Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes. The post Biocon signs licensing and supply pact with Biomm S.A

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

FEBRUARY 27, 2024

Amgen drug development highlights – November 2023 In November 2023, Phase II trial results for immunotherapy tarlatamab demonstrated an ability to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer trial patients.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

pharmaphorum

APRIL 1, 2022

Congress and the White House to curtail prescription drug prices, many experts continue to point to biosimilars and their promising potential to usher in competition, increase access, and drive down costs for patients—and the U.S. And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko.

Biosimilars 59

Biosimilars Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Pathway

FEBRUARY 21, 2023

Hetero Labs Limited-Walk-In Interviews for Production On 26th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 17, 2023

Hetero Labs Limited-Walk-In Drive for Any Graduate in Production- API On 19th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

DECEMBER 7, 2022

Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics. Time: 10:00 AM Onwards. hetero.com.

Biosimilars 87

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 87

Pharma Pathway

JANUARY 5, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced On 6th & 7th Jan’ 2023. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 4, 2023

Hetero Labs Limited-Campus Drive for B.Sc /B.Pharm/ M.Sc/ BCCA/ ITI Fitter/ Diploma/ B.Com/ Diploma Freshers On 6th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 27, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & experienced in Production/ Packing/ QC/ QA/ Stores On 4th March 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 71

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 71

Express Pharma

APRIL 2, 2025

For pharmaceutical companies, this creates both opportunity and urgency: drugs that demonstrate clear clinical benefit could gain swift recognition, while those without competitive differentiation may be deprioritised in treatment algorithms.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Big Molecule Watch

JUNE 6, 2023

On May 26, 2023, the European Commission granted the marketing authorization to Samsung Bioepis for EPYSQLI, a biosimilar referencing SOLIRIS (eculizumab) developed by Alexion for the treatment of the paroxysmal nocturnal hemoglobinuria (PNH) that had global sales of approximately $5 trillion last year.

Biosimilars 59

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The entire pharma industry will be affected by the fallout.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Express Pharma

JUNE 28, 2024

billion in 2023 to $17.9 However, balancing affordability and accessibility with clinical efficacy remains a challenge that pharmaceutical companies must continue to navigate.” Primarily, the loss of patent protection for several drugs, such as Evenity, will lead to the launch of more generics and biosimilars.

Biosimilars 105

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 83

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 83

European Pharmaceutical Review

APRIL 13, 2023

Legislative hurdles aside, in the same way as any other pharmaceutical companies, psychedelics companies will need to obtain regulatory approvals in the countries where they will carry out clinical trials or market products. Sian Banks is a Solicitor within Pinsent Masons’ international intellectual property group.

Biosimilars 131

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 131

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The entire pharma industry will be affected by the fallout.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 89

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 89

European Pharmaceutical Review

NOVEMBER 8, 2022

2) limiting the scope and number of patents asserted in litigation against proposed biosimilar entrants. 4) prohibiting ‘product hopping’ and interference with generic and biosimilar substitutions. 5) monitoring access to biosimilars. 3) policing anticompetitive settlements between competing drug manufacturers.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 95

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 95